Cabaletta Bio Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | 212,695,200.0 | 315,333,400.0 | 107,703,400.0 | 57,914,000.0 | – | – | – | – | – | – | 251.5 | 210.2 | 92.5 | 58.0 | 70.5 | 42.3 | 56.7 | 143.6 | – | – | – | |
| – | – | – | – | – | – | – | 2.4 | 1.3 | 2.1 | 2.1 | 2.7 | 2.6 | 2.1 | 2.7 | 0.9 | 0.5 | 0.3 | 0.2 | 2.6 | 3.2 | 2.9 | 4.2 | 4.3 | 3.8 | 1.9 | 1.3 | 0.8 | 0.6 | 0.5 | 1.7 | 2.0 | 2.9 | 2.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 204.2 | 168.4 | 49.8 | 17.4 | -23.5 | -26.5 | -19.8 | 119.8 | – | – | – | |
| – | – | – | – | – | – | – | -5.0% | -11.7% | -9.0% | -10.4% | -9.4% | -11.8% | -14.3% | -10.8% | -32.8% | -68.1% | -140.9% | -249.5% | -17.8% | -16.6% | -9.6% | -7.5% | -5.4% | -7.8% | -20.4% | -35.9% | -78.3% | -140.4% | -114.5% | -51.1% | -58.8% | -47.4% | -32.9% | |
| Margins | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | -27,800,000.0% | -49,900,000.0% | -73,300,000.0% | -83,600,000.0% | – | – | – | – | – | – | -58.4% | -47.8% | -37.7% | -39.4% | -104.5% | -110.1% | -112.6% | -107.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -3,860,300,000.0% | -4,175,000,000.0% | -4,631,300,000.0% | -4,960,000,000.0% | – | – | – | – | – | – | -1,861.8% | -2,138.0% | -2,496.9% | -2,855.4% | -7,639.9% | -8,195.7% | -9,149.8% | -9,976.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -3,854,300,000.0% | -4,171,000,000.0% | -4,628,900,000.0% | -4,953,300,000.0% | – | – | – | – | – | – | -1,687.7% | -1,916.9% | -2,244.0% | -2,597.6% | -7,073.5% | -7,738.7% | -8,808.7% | -9,677.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -3,032,100,000.0% | -3,400,900,000.0% | -3,527,500,000.0% | -3,946,400,000.0% | – | – | – | – | – | – | -1,352.5% | -1,647.1% | -1,886.8% | -2,084.0% | -5,520.9% | -5,935.3% | -6,486.4% | -7,341.8% | – | – | – | |
| Returns | ||||||||||||||||||||||||||||||||||
| – | – | – | – | -45.8% | -23.8% | – | -12.2% | -15.9% | -20.6% | -25.0% | -30.4% | -34.4% | -38.0% | -35.8% | -39.2% | -46.4% | -53.7% | -59.6% | -50.7% | -61.0% | -33.0% | -38.8% | -28.7% | -34.7% | -45.1% | -59.8% | -76.1% | -104.3% | -80.8% | -113.7% | -149.8% | -169.8% | -86.1% | |
| – | – | – | -35.7% | -19.6% | -23.2% | -17.9% | -12.0% | -15.5% | -20.1% | -24.2% | -29.1% | -33.1% | -36.0% | -34.0% | -36.6% | -43.6% | -50.3% | -55.8% | -45.3% | -54.0% | -31.1% | -36.1% | -26.7% | -32.0% | -41.4% | -51.0% | -62.6% | -76.8% | -64.3% | -83.5% | -101.7% | -118.4% | -70.6% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -79 | -92 | -126 | -113 | -190 | -168 | -171 | -163 | -154 | -113 | -125 | -39 | -59 | -94 | -206 | |
| – | – | -31.3% | -31.3% | 42.7% | 97.6% | -34.8% | 97.8% | 97.6% | 97.4% | 96.5% | 95.5% | 96.3% | 94.8% | 95.1% | 93.4% | 93.9% | 93.6% | 93.7% | 89.4% | 88.6% | 94.3% | 92.9% | 93.1% | 92.2% | 91.8% | 85.2% | 82.3% | 73.6% | 79.5% | 73.5% | 67.9% | 69.7% | 82.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | |
| Per Share | ||||||||||||||||||||||||||||||||||
| – | – | – | -3.36 | -1.05 | -1.25 | -0.60 | -0.70 | -0.92 | -1.12 | -1.27 | -1.43 | -1.50 | -1.56 | -1.61 | -1.63 | -1.71 | -1.77 | -1.76 | -1.80 | -1.58 | -1.47 | -1.42 | -1.52 | -1.56 | -1.82 | -2.11 | -2.31 | -2.56 | -2.33 | -1.55 | -1.64 | -1.57 | -1.20 | |
| – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.08 | 0.08 | 0.08 | 0.03 | 0.03 | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 | |
| -0.11 | – | -0.74 | -2.94 | 2.29 | 5.23 | -1.16 | 5.76 | 5.78 | 5.41 | 5.05 | 4.71 | 4.35 | 4.10 | 4.51 | 4.16 | 3.69 | 3.30 | 2.96 | 3.55 | 2.59 | 4.45 | 3.66 | 5.32 | 4.50 | 4.04 | 3.52 | 3.03 | 2.46 | 2.88 | 1.36 | 1.10 | 0.92 | 1.39 | |
| – | – | – | -0.82 | -0.37 | -0.65 | -0.47 | -0.70 | -0.85 | -1.00 | -1.12 | -1.18 | -1.31 | -1.23 | -1.32 | -1.24 | -1.36 | -1.55 | -1.62 | -1.66 | -1.38 | -1.24 | -1.14 | -1.22 | -1.34 | -1.53 | -1.69 | -1.80 | -1.97 | -1.72 | -1.18 | -1.29 | -1.28 | -1.02 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.